ResMed Inc
(BSP:R1MD34)
R$
368.7
0.14 (0.04%)
Market Cap: 216.49 Bil
Enterprise Value: 218.91 Bil
PE Ratio: 32.69
PB Ratio: 6.97
GF Score: 87/100 Resmed Inc at Sanford C Bernstein Strategic Decisions Conference Transcript
Jun 01, 2022 / 05:30PM GMT
Release Date Price:
R$243.12
Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst
We are ready to go. Thanks, everybody, for joining. I'm Lee Hambright, U.S. medical devices analyst at Bernstein, and we are thrilled to host Mick Farrell, ResMed's CEO. We are scheduled for a 50-minute fireside chat. Just a reminder, you can submit questions anytime through Pigeonhole, or you can raise your hand and we can get them in that way.
So Mick, we really appreciate you joining us. Thanks for being here.
Michael J. Farrell
ResMed Inc. - CEO & Director
I'm happy to be here.
Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst
So you've served as ResMed's CEO for nearly a decade. Very happy to welcome you here to SDC. I think we'll jump right into Q&A.
Questions & Answers
Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst
Maybe just starting at a very high level. You
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot